220 related articles for article (PubMed ID: 31167750)
21. Reply to Valerian Ciprian Lucan, Salvatore Butticè, Rosa Pappalardo, Carlo Magno's Letter to the Editor re: Mark W. Ball, Nathaniel Readal, Phillip M. Pierorazio, Mohamad E. Allaf. Splitting One Kidney into Two: Robotic Partial Kidney Transplant in a Porcine Model. Eur Urol 2016;69:968-9.
Ball MW; Allaf ME
Eur Urol; 2016 Sep; 70(3):e82. PubMed ID: 26995330
[No Abstract] [Full Text] [Related]
22. Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
Mir MC; Derweesh IH; Autorino R
Eur Urol; 2017 Nov; 72(5):e129-e130. PubMed ID: 28528815
[No Abstract] [Full Text] [Related]
23. Re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019:76:136-7.
Marconi L; Bensalah K; Bex A;
Eur Urol; 2019 Jul; 76(1):e12-e13. PubMed ID: 30922689
[No Abstract] [Full Text] [Related]
24. Reply to Chen Cai, Huamao Ye, and Bing Liu's letter to the editor re: Francesco Greco, Riccardo Autorino, Koon H. Rha, et al. Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysis. Eur Urol 2013;64:314-22.
Greco F; Autorino R
Eur Urol; 2013 Aug; 64(2):e33-4. PubMed ID: 23628494
[No Abstract] [Full Text] [Related]
25. Reply to Yan Shibing and Wei Qiang's Letter to the Editor re: Morgan Rouprêt, Marko Babjuk, Eva Compérat, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868-79.
Rouprêt M
Eur Urol; 2016 Mar; 69(3):e51-2. PubMed ID: 26461109
[No Abstract] [Full Text] [Related]
26. Reply to Nikolaos Grivas, Sanchia Goonewardene, Wouter Everaerts, Nikolaos Kalampokis's Letter to the Editor re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2, Project). Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.07.004.
Mari A; Tellini R; Ficarra V; Carini M; Minervini A;
Eur Urol Focus; 2021 Sep; 7(5):1212-1213. PubMed ID: 33384273
[No Abstract] [Full Text] [Related]
27. Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):e24-5. PubMed ID: 25257032
[No Abstract] [Full Text] [Related]
28. Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That's the Question!
Ohashi R; Hartmann A; Martignoni G; Moch H
Eur Urol; 2021 Jul; 80(1):e17-e18. PubMed ID: 33934927
[No Abstract] [Full Text] [Related]
29. Reply to Daniel D. Shapiro, Jose A. Karam, Viraj A. Master, et al.'s Letter to the Editor re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610.
Yip W; Ghoreifi A; Djaladat H
Eur Urol Oncol; 2023 Dec; 6(6):637. PubMed ID: 37316397
[No Abstract] [Full Text] [Related]
30. Reply to Gianluca Giannarini, Alessandro Crestani, Andrea Porzionato, Veronica Macchi, and Vincenzo Ficarra's Letter to the Editor re: Massimiliano Spaliviero, Bing Ying Poon, Christoph A. Karlo, et al. An Arterial Based Complexity (ABC) Scoring System to Assess the Morbidity Profile of Partial Nephrectomy. Eur Urol 2016;69:72-9.
Touijer KA
Eur Urol; 2016 Mar; 69(3):e55-6. PubMed ID: 26476715
[No Abstract] [Full Text] [Related]
31. Reply to Mengda Zhang and Long Wang's Letter to the Editor re: Francesco Porpiglia, Enrico Checcucci, Daniele Amparore, et al. Three-dimensional Augmented Reality Robot-assisted Partial Nephrectomy in Case of Complex Tumours (PADUA ≥ 10): A New Intraoperative Tool Overcoming the Ultrasound Guidance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.11.024.
Amparore D; Checcucci E; Fiori C; Porpiglia F
Eur Urol; 2020 Jun; 77(6):e163-e164. PubMed ID: 32279902
[No Abstract] [Full Text] [Related]
32. Reply to Milan Hora's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
Macklin PS; Sullivan ME; Tapping CR; Webster GM; Roberts ISD; Verrill CL; Browning L
Eur Urol; 2019 Oct; 76(4):e97. PubMed ID: 31255422
[No Abstract] [Full Text] [Related]
33. Reply to Brett Delahunt, Hemamali Samaratunga, Lars Egevad's Letter to the Editor re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31. Should Chromophobe Renal Cell Carcinoma Be Graded?
Avulova S; Cheville JC; Lohse CM; Potretzke AM
Eur Urol; 2021 May; 79(5):e143-e144. PubMed ID: 33637366
[No Abstract] [Full Text] [Related]
34. Reply to M.V. Meng's Letter to the Editor re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9 and P.L. Steinberg et al. re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9. Eur Urol 2007;51:572-3.
O'Kane HF; Nambirajan T
Eur Urol; 2007 May; 51(5):1449. PubMed ID: 17229516
[No Abstract] [Full Text] [Related]
35. Reply to Maxine G. Tran, Ravi Barod, and Axel Bex's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
Macklin PS; Sullivan ME; Tapping CR; Webster GM; Roberts ISD; Verrill CL; Browning L
Eur Urol; 2019 Jun; 75(6):e177-e178. PubMed ID: 30827695
[No Abstract] [Full Text] [Related]
36. Re: Outcomes following partial nephrectomy by tumor size P. L. Crispen, S. A. Boorjian, C. M. Lohse, T. S. Sebo, J. C. Cheville, M. L. Blute and B. C. Leibovich J Urol 2008; 180: 1912-1917.
Cimen HI; Serefoglu EC; Balbay MD
J Urol; 2009 Sep; 182(3):1232; author reply 1232. PubMed ID: 19625039
[No Abstract] [Full Text] [Related]
37. Reply to Nirmish Singla and Vitaly Margulis's Letter to the Editor re: Geraldine Pignot, Antoine Thiery-Vuillemin, Jochen Walz, et al. Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.018. The Next Surgical Frontier in Kidney Cancer: Nephrectomy After Immune Checkpoint Inhibition: Nephrectomy After Immunotherapy: The Duration of Treatment Exposure is Probably Decisive.
Pignot G; Thiery-Vuillemin A; Walz J; Bigot P; Bensalah K; Gravis G; Barthélémy P
Eur Urol; 2020 Aug; 78(2):e81-e82. PubMed ID: 32389444
[No Abstract] [Full Text] [Related]
38. Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
Eur Urol; 2016 Nov; 70(5):e141-e142. PubMed ID: 27157996
[No Abstract] [Full Text] [Related]
39. Reply to E. Jason Abel Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
Eur Urol; 2016 Jun; 69(6):e119-20. PubMed ID: 26776936
[No Abstract] [Full Text] [Related]
40. Reply to Yang Zhao, Wenda Wang, and Yushi Zhang's Letter to the Editor re: Sounak Gupta, Christine M. Lohse, Ross Rowsey, et al. Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex-associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome. Eur Urol 2022;81:229-33.
Gupta S; Lohse CM; Jimenez RE; Cheville JC
Eur Urol; 2022 Oct; 82(4):e117. PubMed ID: 35810047
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
